1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Optic Neuritis-Pipeline Insights, 2016

Optic Neuritis-Pipeline Insights, 2016

  • November 2016
  • -
  • Delve Insight
  • -
  • 60 pages


DelveInsight’s, “ Optic Neuritis-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Optic Neuritis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Optic Neuritis. DelveInsight’s Report also assesses the Optic Neuritis therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope
- The report provides competitivepipeline landscape of Optic Neuritis
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Optic Neuritis pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Optic Neuritis and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

Optic Neuritis-Pipeline Insights, 2016

Illustrative Table of contents

- Optic Neuritis Overview
- Optic Neuritis Pipeline Therapeutics
- Optic Neuritis Therapeutics under Development by Companies
- Optic Neuritis Filed and Phase III Products
- Comparative Analysis
- Optic Neuritis Phase II Products
- Comparative Analysis
- Optic Neuritis Phase I and IND Filed Products
- Comparative Analysis
- Optic Neuritis Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Optic Neuritis - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Optic Neuritis - Discontinued Products
- Optic Neuritis - Dormant Products
- Companies Involved in Therapeutics Development for Optic Neuritis
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Optic Neuritis, 2016
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2016
- Comparative Analysis Phase II Products, 2016
- Comparative Analysis Phase I and IND Filed Products, 2016
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2016
- Drug Candidates Profiles
- Optic Neuritis Assessment by Monotherapy Products
- Optic Neuritis Assessment by Combination Products
- Optic Neuritis Assessment by Route of Administration
- Optic Neuritis Assessment by Stage and Route of Administration
- Optic Neuritis Assessment by Molecule Type
- Optic Neuritis Assessment by Stage and Molecule Type
- Optic Neuritis Therapeutics - Discontinued Products
- Optic Neuritis Therapeutics - Dormant Products
- Products under Development by Companies, 2016

List of Figures

- Number of Products under Development for Optic Neuritis, 2016
- Filed and Phase III Products, 2016
- Phase II Products, 2016
- Phase I and IND Filed Products, 2016
- Discovery and Pre-Clinical Stage Products, 2016
- Optic Neuritis Assessment by Monotherapy Products
- Optic Neuritis Assessment by Combination Products
- Optic Neuritis Assessment by Route of Administration
- Optic Neuritis Assessment by Stage and Route of Administration
- Optic Neuritis Assessment by Molecule Type
- Optic Neuritis Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Europe Market Report for Fundus Cameras 2017 - MedCore

Europe Market Report for Fundus Cameras 2017 - MedCore

  • $ 6495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description General Report Contents - Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends - Market Drivers & Limiters for each chapter segment - Competitive Analysis for each chapte ...

Europe Market Report for Slit Lamps 2017 - MedCore

Europe Market Report for Slit Lamps 2017 - MedCore

  • $ 5995
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description General Report Contents - Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends - Market Drivers & Limiters for each chapter segment - Competitive Analysis for each chapte ...

Glaucoma Therapeutics Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024

Glaucoma Therapeutics Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Glaucoma Therapeutics Market: Overview Glaucoma is an ocular disease which affects the optic nerve of the iris and progression of the same results into vision loss and blindness. The treatment for glaucoma ...


Download Unlimited Documents from Trusted Public Sources

Related Market Segments :

Eye Disease

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.